INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 455m ago
HOUSE PTR55m ago
SEC 13F55m ago
ROBINHOOD CHAIN55m ago
Corporate insider
SA

Scott Robert A

DirectorCIK 0001248520

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score15
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
SA
Scott Robert ADirector
ARQTArcutis Biotherapeutics, Inc.
Grant or award
A—
20.5K sh
Oct 23, 2026Oct 28, 2026
traded Oct 23, 2026
+5dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Arcutis Biotherapeutics, Inc.Director · Oct 28, 2026
15
SA
Scott Robert ADirector
ARQTArcutis Biotherapeutics, Inc.
Grant or award
A
—
8,663 sh
Oct 23, 2026
Oct 28, 2026
traded Oct 23, 2026
+5d
SEC FORM 4

Evidence

15
SA
Scott Robert ADirector
ARQTArcutis Biotherapeutics, Inc.
Grant or award
A—
2,819 sh
Oct 23, 2026Oct 28, 2026
traded Oct 23, 2026
+5dSEC FORM 4

Evidence